Felodipine-Induced Dilatation of Epicardial Coronary Arteries A Randomized, Double-Blind Study

Emanuelsson, Håkan; Ekstrom, Lars; Hjaltnarson, Ake; Jonsteg, Christina; Schlossman, David
January 1986
Angiology;Jan1986, Vol. 37 Issue 1, p1
Academic Journal
Dilatation of large coronary arteries is of potential value in the treatment of angina pectoris. In this double-blind study, the acute effect of felodipine or placebo on coronary artery dilatation was studied in patients with severe angina pectoris with the aid of coronary arteriography. There were two parallel groups, one with 9 patients who received felodipine, the other with 12 patients who received placebo. Measurements of vessel diameters were performed at a proximal position of the affected artery, at the site of the stenosis, and distal to the lesion. The mean plasma felodipine concentration was 17+/-6 nmol/l. The systolic blood pressure was reduced from 156+/-15 to 145+/-13 mm Hg after felodipine (p < 0.05), but was unaffected by placebo. The heart rate and arterial catecholamine levels were basically unchanged in both groups of patients. The proximal arterial segment was dilated 7% after felodipine (p = 0.05), the stenosis area 9% (N.S.) and the distal part of the vessel 7% (p < 0.05). There were no changes in coronary diameters in the placebo group. In conclusion, felodipine dilates large coronary arteries, and this mode of action may be valuable in the treatment of patients with coronary artery disease, especially in cases where coronary spasm is a prominent feature


Related Articles

  • Effects of Trimetazidine on Heart Rate Variability and Left Ventricular Systolic Performance in Patients with Coronary Artery Disease After Percutaneous Transluminal Angioplasty. Birand, Ahmet; Kudaiberdieva, Gulmira Z.; Batyraliev, Talantbek A.; Akgul, Ferit; Usal, Ayhan // Angiology;May1997, Vol. 48 Issue 5, p413 

    Fifty-one patients (mean age 51.6 ±7.1 years) with angiographically proven coronary artery disease (CAD) entered the study. In 26 patients (Group I), trimetazidine treatment started twenty-four hours after percutaneous transluminal coronary angioplasty (PTCA). Another 25 patients (Group II)...

  • Exercise Tests in Patients With Severe Angina Pectoris: An Angiographic Correlation. Eshchar, Y.; Yahini, J. H.; Atlas, P.; Kishon, Y.; Deutsch, V.; Neufeld, H. N. // Angiology;Jan1980, Vol. 31 Issue 1, p32 

    Graded submaximal ergometric tests were performed on 60 patients who suffered from clinically severe angina pectoris, and the results were correlated with their coronary angiograms. The test was positive in 44, negative in 9, and undetermined in 7 patients (defined as failure to reach the...

  • Heart rate variability and turbulence to determine true coronary artery disease in patients with ST segment depression without angina during exercise stress testing. Celik, Atac; Ozturk, Ahmet; Ozbek, Kerem; Kadi, Hasan; Koc, Fatih; Ceyhan, Koksal; Erkorkmaz, Unal // Clinical & Investigative Medicine;Dec2011, Vol. 34 Issue 6, pE349 

    Purpose: ST segment depression without angina during an exercise stress test causes diagnostic problems, particularly in non-diabetic patients. Heart rate variability (HRV) and heart rate turbulence (HRT) are used to evaluate the changes in cardiac autonomic functions and are also both decreased...

  • Spinal Cord Stimulation Significantly Improves Refractory Angina Pectoris-A Local Experience: Spinal Cord Stimulation in Refractory Angina. Chua, Roderick; Keogh, Anne // Heart, Lung & Circulation;Mar2005, Vol. 14 Issue 1, p3 

    Background:: Severe refractory angina pectoris can occur in end-stage coronary artery disease despite maximal medical and revascularization therapy. Spinal cord stimulation is an under-utilized but well-established modality for the treatment of intractable angina pain. Aim:: To illustrate the...

  • The Role of Heart Rate Modulation for Care of Patients with Coronary Artery Disease and Heart Failure. Borer, Jeffrey S.; Fox, Kim; Tardif, Jean-Claude // Medical Roundtable: Cardiovascular Edition;Winter2011, Vol. 2 Issue 1, p23 

    The discussion focused primarily on: (1) effects of heart rate in coronary artery disease and heart failure, (2) insights regarding the CASS registry, (3) modalities used for heart rate modulation, including F channel blocker ivabradine, and (4) results of clinical trial studies with ivabradine...

  • Efficacy of Pentoxifylline in Patients with Stable Angina Pectoris. Insel, Jerald; Halle, A. Arthur; Mirvis, David M. // Angiology;Jun1988, Vol. 39 Issue 6, p514 

    Pentoxifylline, a methyl xanthine derivative, improves symptoms of peripheral vascular disease probably by reducing whole blood viscosity. The authors assessed the value of this agent in treating myocardial ischemia in 11 patients with angiographically documented coronary artery disease and...

  • Brachial Artery Flow Pattern and Clinical Backgrounds in Patients with Angina Pectoris. Sugawara, Hirobumi; Kubota, Isao; Tomoike, Hitonobu // Angiology;Jan1998, Vol. 49 Issue 1, p25 

    Blood flow velocity of the brachial artery was measured noninvasively by ultrasound pulsed Doppler technique under the guidance of a B-mode ultrasound image in 56 patients with angina pectoris. There was no significant stenosis along the brachial artery on a B-mode image. The authors...

  • ANGINA PECTORIS. Shapiro, Shepard // Angiology;Feb1961, Vol. 12 Issue 2, p53 

    Angina pectoris occurs when the oxygen supply to the myocardium falls below the physiologic requirement of the moment. This anoxia is reversible and when the oxygen supply becomes adequate the angina attack subsides. These attacks can be prevented or controlled by coronary vasodilator drugs. The...

  • Medical Management of Angina Pectoris. Burch, G. E. // Angiology;Oct1979, Vol. 30 Issue 10, p667 

    Discusses the treatment or medical management of angina pectoris. Aspects of medical management for effective care of patients with angina pectoris; Need for the application of the existing knowledge to the best interest of patients suffering from various syndromes of ischemic heart disease;...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics